Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03085095
Title A Study to Evaluate the Safety and Efficacy of Relugolix in Men With Advanced Prostate Cancer (HERO)
Recruitment Completed
Gender male
Phase Phase III
Variant Requirements No
Sponsors Myovant Sciences GmbH
Indications

prostate adenocarcinoma

Therapies

Relugolix

Leuprolide

Age Groups: adult | senior
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUT


No variant requirements are available.